Table 1 Rates of non‐calcified nodules and lung cancer detected during the 2 year study period.
| N | % | |
|---|---|---|
| NCN on prevalence scan | 105 | 20.7 |
| NCN stable at 2 years | 97 | 21.6 |
| NCN growth on incidence scan | 2 | 0.4 |
| NSCLC stage 1 | 1 | 0.2 |
| New NCN on incidence scan | 6 | 1.3 |
| Neuroendocrine tumour | 1 | 0.2 |
| Lung cancer detected in 2 years | 6 | 1.3 |
| Prevalence lung cancer | 2 | 0.4 |
| NSCLC stage 1 | 1 | 0.2 |
| Small cell lung cancer | 1 | 0.2 |
| Incidence lung cancer | 3 | 0.7 |
| NSCLC stage 1 | 1 | 0.2 |
| Neuroendocrine tumour | 1 | 0.2 |
| Small cell lung cancer | 1 | 0.2 |
| Interval lung cancer | 1 | 0.2 |
NCN, non‐calcified nodule; NSCLC, non‐small cell lung cancer.
The values are the numbers of individual abnormalities and the percentage represents the proportion of the total study population with this finding.